Start Learning Free

Before You Begin

Question #46547

Difficulty: 8/10 | 🟢 Free

The Question

A patient undergoing an allogeneic kidney transplant is administered a bioactive molecule produced by the fungus Trichoderma polysporum. If the patient concurrently harbors an undetected, early-stage malignant tumor, which of the following represents the most probable impact of this drug on the tumor's progression?

Options

  • A.

    Accelerated metastasis, as the drug suppresses Cell-Mediated Immunity (CMI), thereby facilitating the tumor's evasion of immunosurveillance.

  • B.

    Tumor regression, as the drug acts as a biological response modifier that activates cytotoxic T-cells to destroy malignant cells.

  • C.

    Unaltered tumor growth, because the drug selectively inhibits humoral immunity without affecting the T-lymphocytes responsible for tumor destruction.

  • D.

    Localized necrosis of the tumor, as the drug directly inhibits the rapid mitotic divisions characteristic of neoplastic cells.

Check Your Answer

Correct Answer

Step-by-Step Solution

Explanation

How the Examiner Thinks

Comparative_Analysis

Sharpen your ability to evaluate multiple scenarios and distinguish between competing potential answers.

Concepts Behind This Question

MALT_Structure|T-lymphocytes|Immunosuppressants

Why This Question Is Tricky

Common Mistakes

Conceptual Pivot: This question tests the synthesis of two distinct NCERT chapters ('Microbes in Human Welfare' and 'Human Health and Disease').

Students often memorize 'Cyclosporin A = organ transplant' without connecting its underlying mechanism (suppression of Cell-Mediated Immunity) to the other critical role of CMI: cancer immunosurveillance.

The trap lies in confusing immunosuppressants with biological response modifiers (like alpha-interferon) or assuming the drug only affects the transplanted organ.

Quick Facts About This Question

Question Information

SubjectBiology
ChapterHuman Health and Disease - Class 12
ConceptMetastasis
Difficulty8
Cognitive Load5
Target Solve Time120 sec
AccessFree